Eurofins stock gains 1.32 percent as H1 margins widen

Published on 09/28/2026 at 13:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins stock reflects a 23.7 percent adjusted EBITDA margin for H1 2026 on September 28, 2026. Morgan Stanley cut its target to EUR 64.50 from EUR 68.50 on September 8.

Wissenschaftlerin analysiert Lebensmittelproben mit Pipette im modernen Testlabor — Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Eurofins stock was trading at EUR 78.38 on Euronext Paris on September 28, 2026 at 12:56 p.m. CEST, up 1.32 percent from EUR 77.36. The laboratory services group enters the session with H1 2026 adjusted EBITDA margin at 23.7 percent and earnings per share growth of 29 percent.

Margins widen in H1 2026

According to Eurofins, H1 2026 results published on July 23, 2026 showed 130 basis points of adjusted EBITDA margin expansion and 29 percent EPS growth. The company also maintained its mid-term 2027 adjusted EBITDA margin objective of 24 percent.

The H1 earnings call placed the improvement beside a more moderate operating trend. According to Yahoo Finance on July 23, 2026, organic revenue growth was 2.7 percent, adjusted EPS reached EUR 1.55 and free cash flow to the firm rose 46 percent year over year to EUR 403 million.

Analyst target stays below price

Valuation remains a counterweight to the margin progress. MarketScreener reported on September 8, 2026 that Morgan Stanley lowered its rating from equal weight to underweight and cut its price target to EUR 64.50 from EUR 68.50.

The concern cited in that assessment was organic growth running below peers and Eurofins' medium-term target. For investors, the key tension is therefore visible in the H1 figures: profitability improved faster than the 2.7 percent organic growth rate.

Stock stays near yearly high

At EUR 78.38, the share was 1.06 percent below its 52-week high of EUR 79.22 and above its 52-week low of EUR 54.86 on September 28, 2026. The session range was EUR 77.26 to EUR 78.66, with volume of 38,147 shares and market capitalization of EUR 13.5 billion.

Eurofins has scheduled investor days in Amersfoort on October 23, 2026 and Toronto on November 11, 2026, according to Eurofins. Those dates give the market another opportunity to assess progress toward the company's margin and growth objectives.